Skip to content

Clinical Assessment of Patients With High Bone Mass Due to Mutation in Lrp5

Clinical Assessment of Patients With High Bone Mass Due to Mutation in Low Density Lipoprotein l Receptor 5

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01199094
Enrollment
38
Registered
2010-09-10
Start date
2009-01-31
Completion date
2010-06-30
Last updated
2010-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteopetrosis

Keywords

low density lipoprotein receptor 5, high bone mass, autosomal dominant osteopetrosis type I, bone turnover markers

Brief summary

The aim of the study is to describe patients with a high bone mass phenotype due to a mutation in the low density lipoprotein l receptor 5 gene (LRP5) and compare them with age and sex matched controls. Moreover, bone density and microarchitecture as well as markers of bone metabolism are evaluated

Detailed description

Cases and controls are closely matched on age and sex and evaluated cross-sectionally. Dual x-ray absorptiometry (DXA) and high resolution peripheral quantitative computed tomography (HR-pQCT) are used in order to evaluate bone density as well as microarchitecture. Bone turnover markers and body composition are also measured.

Interventions

None listed

Sponsors

Odense University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
8 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Lrp5 mutation/ADOI

Exclusion criteria

* Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Bone microarchitecture as assessed by high resolution quantitative computed tomography (HR-pQCT)12 weeksHR-pQCT is used to evaluate bone microarchitecture, i.e. bone trabeculae, cortical thickness and trabecular number. Aim is to test if the microarchitecture of these patients are different that observed in normal controls

Secondary

MeasureTime frameDescription
Changes in bone turnover markers12 weeksMarkers of bone resorption and formation are investigated.
Bone mineral density12 weeksDXA is used to evaluate bone mineral density at total hip, spine, whole body and forearm.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026